Overview

Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery

Status:
Unknown status
Trial end date:
2007-02-01
Target enrollment:
0
Participant gender:
All
Summary
To study the activity of chemotherapy with Gemzar-carboplatin in the preoperative setting for operable stages of non-small-cell lung cancer and to identify novel molecular markers correlated with chemosensitivity and prognosis
Phase:
Phase 2
Details
Lead Sponsor:
Hospital Authority, Hong Kong
Collaborator:
Eli Lilly and Company
Treatments:
Carboplatin
Gemcitabine
Criteria
Inclusion Criteria:

- Histologically or cytologically proven, newly diagnosed primary bronchogenic non-small
cell lung cancer

- Measurable or evaluable tumour on chest X-ray or CT scan.

- No multiple ipsilateral or contralateral parenchymal tumours

- Stage I(exceptT1N0),II,IIIa disease as shown by PET-CT